2016 Press Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
December 9, 2016 - Edge Therapeutics Announces Publication of Phase 1/2 Data on EG-1962 for the Treatment of Aneurysmal Subarachnoid Hemorrhage in Peer-Reviewed Medical Journal, Stroke
Read More
November 2, 2016 - Edge Therapeutics to Present at Investor Conferences in November
Read More
November 1, 2016 - Edge Therapeutics Reports Third Quarter Financial Results
Read More
October 25, 2016 - Edge Therapeutics to Host Conference Call on November 1, 2016 to Discuss Third Quarter Financial Results
Read More
October 17, 2016 - Edge Therapeutics Appoints Chief Operating Officer and Makes Inducement Grant under NASDAQ Rule 5635(c)(4)
Read More
September 8, 2016 - Edge Therapeutics to Present at the Leerink Partners Rare Disease & Immuno-Oncology Roundtable Series and Participate in Additional Investor Conferences in September
Read More
September 6, 2016 - Edge Therapeutics Announces Additional Pharmacokinetic Data Supporting the Potential Clinical and Health Economic Impact of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Read More
September 1, 2016 - Edge Therapeutics to Present Additional Data from Phase 1/2 NEWTON Study of EG-1962 at Two Scientific Conferences in September
Read More
August 3, 2016 - Edge Therapeutics Reports Second Quarter Financial Results and Recent Highlights
Read More
August 2, 2016 - Edge Therapeutics Announces Closing of $20 Million Debt Facility with Hercules Capital, Inc.
Read More
July 29, 2016 - Edge Therapeutics Announces First Patient Treated in Phase 3 NEWTON 2 Study of EG-1962 in Adult Patients with Aneurysmal Subarachnoid Hemorrhage
Read More
July 27, 2016 - Edge Therapeutics to Host Conference Call on August 3, 2016 to Discuss Second Quarter Financial Results
Read More
July 6, 2016 - Edge Therapeutics Announces Appointment of Harry J. Sacks, M.D., FAAP, as Vice President, Clinical Development
Read More
June 24, 2016 - Edge Therapeutics Granted U.S. Patent Covering the Expanded Use of Lead Candidate EG-1962
Read More
June 10, 2016 - Edge Therapeutics’ Chief Accounting and Operations Officer Bert Marchio Receives the New Jersey Tech Council Deal of the Year Award
Read More
June 2, 2016 - Edge Therapeutics to Present at Upcoming Investor Conferences
Read More
May 13, 2016 - Edge Therapeutics Receives FDA Fast Track Designation for EG-1962 for the Treatment of Subarachnoid Hemorrhage
Read More
May 6, 2016 - Edge Therapeutics Chief Financial Officer Andrew J. Einhorn Receives CFO Studio 2016 CFO Success Award
Read More
May 3, 2016 - Edge Therapeutics Reports First Quarter 2016 Financial Results
Read More
April 26, 2016 - Edge Therapeutics to Host a Conference Call on May 3, 2016 to Discuss First Quarter 2016 Financial Results
Read More
April 5, 2016 - Edge Therapeutics to Present at the 15th Annual Needham Healthcare Conference
Read More
March 8, 2016 - Edge Therapeutics Reports Fourth Quarter and Full-Year 2015 Financial Results
Read More
March 2, 2016 - Edge Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference
Read More
March 1, 2016 - Edge Therapeutics to Host a Conference Call on March 8, 2016 to Discuss Fourth Quarter and Full-Year 2015 Financial Results
Read More
February 19, 2016 - Edge Therapeutics Announces New Data Highlighting the Potential Pharmacoeconomic Impact of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Read More
February 10, 2016 - New Data From the Phase 1/2 NEWTON Study of Edge Therapeutics’ EG-1962 to be Presented at the International Stroke Conference 2016
Read More
February 3, 2016 - Edge Therapeutics to Participate in LEERINK Partners 5th Annual Global Healthcare Conference
Read More
January 10, 2016 - Edge Therapeutics to Present at the 34th Annual J.P. Morgan Healthcare Conference
Read More

Printer Friendly Version Print PageE-mail this page Email PageRSS RSS FeedsE-mail Alerts Email AlertsView contacts IR Contacts